Summaries of Product Characteristics (SPC) for Human medicinal products

The summaries of product characteristics (SPC) contain the information relevant to the use of the medicinal products and of importance to health care professionals. The SPCs are published in Finnish; the use of Finnish key words in the search fields is therefore recommended.

Some of the medicinal products contain a condition relevant to the prescribing of the product and not always found in the SPC. The conditions for prescribing and the products covered by this condition are found in the FimeaWeb search.

The SPCs processed as part of the EU centralised marketing authorisation procedure are published by the European Medicines Agency, EMA. Fimea's service contains links to the documents on medicinal products (EPAR PI) on the EMA website. Drugs belonging to the centralised authorisation procedure can be searched in Fimea's service by using an alphabetical list or by entering the product name or ATC code.

The material being published is not necessarily complete or up-to-date due to the technical quality of files submitted to the Finnish Medicines Agency Fimea or earlier to the National Agency for Medicines and the delays in delivery. For this reason, Fimea cannot guarantee that the document on the Internet fully complies with the summary of product characteristics and package leaflet officially approved by a desicion for a marketing authorisation. Only the hard copies of the SPCs and the PLs, which are in accordance with the marketing authorisation, are conclusive.

Summaries of Product Characteristics 181 - 210 of 316
<  Previous 30    |  1  2  3  4  5  6  7  8  9  10  11  |  Next 30   >
Package leaflet	Status for supply	Name of the medicinal product
PL	Resepti	Miochol-E 10 mg-ml jauhe ja liuotin instillaatioliuosta varten, silmän sisään SPC 2022-02-07
PL	Resepti	Miranax 550 mg tabletti, kalvopäällysteinen SPC 2023-03-23
		European Medicines Agency's website: Mirapexin - EMA: EPAR PI Finnish Swedish
		European Medicines Agency's website: Mircera - EMA: EPAR PI Finnish Swedish
PL	Resepti	Mirena 20 mikrog-24 tuntia depotlääkevalmiste, kohtuun SPC 2023-03-21
PL	Resepti	Mirtagav 15 mg, 30 mg 45 mg tabletti SPC 2010-05-05
PL	Resepti	Mirtamerck 15 mg tabletti SPC 2005-05-11
PL	Resepti	Mirtamerck 30 mg tabletti SPC 2005-05-11
PL	Resepti	Mirtamerck 45 mg tabletti SPC 2005-05-11
PL	Resepti	Mirtazapin Actavis 15 mg, 30 mg tabletti, kalvopäällysteinen SPC 2023-05-30
PL	Resepti	Mirtazapin Hexal 15 mg, 30 mg ,45 mg tabletti, kalvopäällysteinen SPC 2021-04-16
PL	Resepti	Mirtazapin Krka 15 mg, 30 mg, 45 mg tabletti, kalvopäällysteinen SPC 2021-11-22
PL	Resepti	Mirtazapin Orion 15 mg, 30 mg, 45 mg tabletti, kalvopäällysteinen SPC 2021-12-23
PL	Resepti	Mirtazapin Orion 15 mg, 30 mg, 45 mg tabletti, suussa hajoava SPC 2021-06-28
PL	Resepti	Mirtazapin ratiopharm 15 mg, 30 mg tabletti, kalvopäällysteinen SPC 2021-09-16
PL	Resepti	Mirtazapin ratiopharm 45 mg tabletti, kalvopäällysteinen SPC 2023-05-30
PL	Resepti	Mirtazapin Sandoz 15 mg, 30 mg, 45 mg tabletti SPC 2024-02-22
PL	Resepti	Mirtazapin Teva 15 mg, 30 mg, 45 mg tabletti, kalvopäällysteinen SPC 2023-03-24
PL	Resepti	Mirtazapine Actavis 15, 30, 45 mg tabletti SPC 2006-01-24
PL	Resepti	Mirtazapine STADA 15 mg, 30 mg, 45 mg tabletti SPC 2010-05-28.doc
		European Medicines Agency's website: Mirvaso - EMA: EPAR PI Finnish Swedish
PL	Resepti	Misbadi 110 mg kapseli, kova SPC 2022-06-01.docx
PL	Resepti	Misbadi 150 mg kapseli, kova SPC 2022-06-01.docx
PL	Resepti	Misbadi 75 mg kapseli, kova SPC 2022-06-01.docx
PL	Resepti	Mitomycin Accord 20 mg injektio-infuusiokuiva-aine liuosta varten-virtsarakkoon SPC 2022-02-08
PL	Resepti	Mitomycin Medac 40 mg jauhe ja liuotin liuosta varten, virtsarakkoon SPC 2024-01-16
PL	Resepti	Mitomycin medac, 1 mg-ml, injektio-infuusiokuiva-aine, liuosta varten virtsarakkoon SPC 2021-02-18
PL	Resepti	Mitomycin Substipharm 20 mg, injektio-infuusiokuiva-aine, liuosta varten SPC 2023-06-09
PL	Resepti	Mitomycin Substipharm 20 mg, jauhe ja liuotin liuosta varten, virtsarakkoon SPC 2023-06-09
PL	Resepti	Mitoxantron Ebewe 2 mg-ml infuusiokonsentraatti, liuosta varten SPC 2020-11-11
<  Previous 30    |  1  2  3  4  5  6  7  8  9  10  11  |  Next 30   >